Please login to the form below
Functional genomics
This page shows the latest Functional genomics news and features for those working in and with pharma, biotech and healthcare.
GSK appoint Tony Wood as chief scientific officer
He has been recognised for his contributions to furthering building capabilities in functional genomics, AI and machine learning.
Latest news
-
GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
The collaboration combines Vir Biotech’s monoclonal antibody platform technology with GSK’s expertise in functional genomics and capabilities in CRISPR screening to identify anti-coronavirus compounds.
-
Roche, Genentech partner with The Weill Neurohub on ten-year neuroscience collaboration
The initial areas of focus for the ATN are neurodegeneration, CRISPR-based therapeutics, protein degradation, functional genomics in human brain cells and sleep mechanisms and circuits.
-
GSK and Vir Biotech expand phase 3 COVID-19 antibody study
The collaboration combines Vir Biotech’s monoclonal antibody platform technology with GSK’s expertise in functional genomics and capabilities in CRISPR screening to identify anti-coronavirus compounds.
-
GSK joins forces with Doudna’s CRISPR lab
Doudna and Weissman will be members of the steering committee, together with GSK’s new head of functional genomics, Chris Miller, who just joined GSK from AbbVie. ... A similar long-term partnership in functional genomics was unveiled by AstraZeneca
-
Gilead drives NASH development with insitro collaboration
To do this, insitro will utilise its Human (ISH) platform, which applies machine learning, human genetics and functional genomics to generate in vitro models and drive therapeutic discovery and development.
More from news
Approximately 2 fully matching, plus 7 partially matching documents found.
Latest Intelligence
-
Cutting through the noise: CRISPR
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery. ... The company has invested heavily in CRISPR and the broader functional genomics platform, and its upcoming move to Cambridge will be
-
Deal Watch October 2018
treatments based on functional genomics discovery. platform. Strategic. collaboration. $1.75B. SQZ Biotech/. ... Gilead has paid $50m upfront to gain access to Tango’s functional genomics‐based discovery platform, for which it has options on up to
More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- The patient voice – the value of patient-reported outcomes in HTA
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- Strategic commitment
- Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
- AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
- NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
- Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer
- Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
- Medmeme appoints Dr Joseph Laudano to medical affairs role
- Gilead announces positive Biktarvy data for HIV and hepatitis B
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Sarepta to submit application for Duchenne muscular dystrophy gene therapy
- Achieving communication excellence by targeting the right channel at the right time
- Successful product commercialisation: what can we learn from the rare disease setting?
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
